Heterocyclic potassium channel inhibitors

US6303637A · kind A · utility

Assignee

• MERCK & CO., INC. · US

Inventors

• Jianming Bao · Scotch Plains, US
• Andrew Kotliar · Highland Park, US
• Frank Kayser · San Francisco, US
• William H. Parsons · Montgomery, US
• Kathleen M. Rupprecht · Cranford, US
• Christopher F. Claiborne · Lansdale, US
• David A. Claremon · Audubon, US
• Nigel J. Liverton · Harleysville, US
• Wayne Thompson · Lansdale, US

Key dates

• Filing date: Oct 21, 1999
• Grant date: Oct 16, 2001
• Expiry date: Oct 21, 2019

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D211/26
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to a class of heterocyclic compounds of Formula I that are useful as potassium channel inhibitors to treat autoimmune disorders, cardiac arrhythmias, and the like. ##STR1##